Antiphosphatidylserine antibodies as diagnostic indicators of antiphospholipid syndrome

Abstract

Background

Antiphospholipid syndrome (APS) is an autoimmune condition that is diagnosed by the presence of at least one of the clinical manifestations (thrombosis and/or pregnancy failure) and one of antiphospholipid antibodies (aPL) laboratory tests. The most relevant aPL are lupus anticoagulant (LA), anti-beta2 glycoprotein I (aβ2GPI) and anticardiolipin (aCL). The clinical significance of other antibodies like anti-phosphatidylserine antibodies (aPS) is still under investigation.

Objectives

The aim of the study was to assess the diagnostic value of aPS antibodies, and to compare their utility to that of other aPL antibodies.

Methods

We conducted a prospective observational study consisting of 212 patients with suspected thrombosis, pregnancy failure, or unexplained, prolonged clotting time. Data on demography, clinical presentation and autoantibody levels were assessed. Descriptive analysis, accuracy analysis, sensitivity, specificity, predictive value and likelihood ratio were calculated for aPS in comparison to other aPL.

Results

The diagnostic value of aPS versus other aPL antibodies revealed the high specificity of aPS (87%), with 70% of aPS-positive patients being confirmed APS. When the aPS test was used as a single test, it was effective for detection of confirmed APS cases (p < 0.01). Among 28 confirmed primary APS cases, 75% of patients were positive for aPS (p < 0.003). Moreover, by using aPS we detected three additional confirmed APS cases and another three probable cases.

Conclusion

Our findings reveal a significant association between aPS and APS, especially when used to diagnosis clinical cases with other negative aPL tests. There is an independent association between aPS and primary APS. In addition, these results demonstrated the advantages of using aPS as a diagnostic test for APS.

Keywords

Antiphospholipid antibodies phosphatidylserine pregnancy failure thrombosis

Get full access to this article

View all access options for this article.

References

Espinosa

Cervera

Font

Reverter

Shoenfeld

. Mechanism of thrombosis in the antiphospholipid syndrome. Immunologia 2003; 22: 53–62.

Lim W. Antiphospholipid antibody syndrome. Hematology Am Soc Hematol Educ Program 2009: 233–239.

Tebo

Jaskowski

Hill

Branch

. Clinical relevance of multiple antibody specificity testing in anti-phospholipid syndrome and recurrent pregnancy loss. Clin Exp Immunol 2008; 154: 332–338.

Martinuzzo

. Laboratory criteria of antiphospholipid syndrome need to be updated or strictly followed? Open Autoimmun J 2010; 2: 28–37.

Miyakis

Lockshin

Atsumi

. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006; 4: 295–306.

Sakai

Atsumi

Ieko

. The effects of phosphatidylserine-dependent antiprothrombin antibody on thrombin generation. Arthritis Rheum 2009; 60: 2457–2467.

Devreese

Hoylaerts

. Laboratory diagnosis of the antiphospholipid syndrome: A plethora of obstacles to overcome. Eur J Haematol 2009; 83: 1–16.

Kahles

Humpich

Steinmetz

Sitzer

Lindhoff-Last

. Phosphatidylserine IgG and beta-2-glycoprotein I IgA antibodies may be a risk factor for ischaemic stroke. Rheumatology (Oxford) 2005; 44: 1161–1165.

Brandt

Triplett

Alving

Scharrer

. Criteria for the diagnosis of lupus anticoagulants: An update. On behalf of the Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the ISTH. Thromb Haemost 1995; 74: 1185–1190.

10.

Noubouossie

Valsamis

Corazza

Rozen

Debaugnies

Demulder

. An automated chemiluminescence immunoassay may detect mostly relevant IgG anticardiolipin antibodies according to revised Sydney criteria. Acta Clin Belg 2012; 67: 184–189.

11.

Deng

Liu

. Reevaluation of predictive value of ACL and anti-β2GP1 antibody for thrombosis in patients with systemic lupus erythematosus: From a perspective of a practical world. Rheumatol Int 2012; 32: 3881–3886.

12.

Egerer

Roggenbuck

Büttner

. Single-step autoantibody profiling in antiphospholipid syndrome using a multi-line dot assay. Arthritis Res Ther 2011; 13: R118–R118.

13.

Pengo

Biasiolo

Bison

. Antiphospholipid antibody ELISAs: Survey on the performance of clinical laboratories assessed by using lyophilized affinity-purified IgG with anticardiolipin and anti-beta2-glycoprotein I activity. Thromb Res 2007; 120: 127–133.

14.

Vikerfors

Johansson

Gustafsson

. Clinical manifestations and anti-phospholipid antibodies in 712 patients with systemic lupus erythematosus: Evaluation of two diagnostic assays. Rheumatology (Oxford) 2013; 52: 501–509.

15.

Parkpian

Verasertniyom

Vanichapuntu

. Specificity and sensitivity of anti-beta2-glycoprotein I as compared with anticardiolipin antibody and lupus anticoagulant in Thai systemic lupus erythematosus patients with clinical features of antiphospholipid syndrome. Clin Rheumatol 2007; 26: 1663–1670.

16.

Jaslow

Carney

Kutteh

. Diagnostic factors identified in 1020 women with two versus three or more recurrent pregnancy losses. Fertil Steril 2010; 93: 1234–1243.

17.

Yetman

Kutteh

. Antiphospholipid antibody panels and recurrent pregnancy loss: Prevalence of anticardiolipin antibodies compared with other antiphospholipid antibodies. Fertil Steril 1996; 66: 540–546.

18.

Okuma

Kitagawa

Takagi

. Investigation of antiphosphatidyl-serine antibody and antiphosphatidyl-inositol antibody in ischemic stroke patients. Clin Dev Immunol 2010; 2010: 439230–439230.

19.

Forastiero

Martinuzzo

. Antigen specificity and clinical relevance of antiphospholipid syndrome-related autoantibodies. Current Rheumatol Rev 2005; 1: 177–178.

20.

Nojima

Kuratsune

Suehisa

Iwatani

Kanakura

. Acquired activated protein C resistance associated with IgG antibodies against beta2-glycoprotein I and prothrombin as a strong risk factor for venous thromboembolism. Clin Chem 2005; 51: 545–552.

21.

Adler

Rote

. Monoclonal antiphosphatidylserine antibody inhibits intercellular fusion of the choriocarcinoma line, JAR. Biol Reprod 1995; 53: 905–910.

22.

Katsuragawa

Rote

Inoue

Narukawa

Kanzaki

Mori

. Monoclonal antiphosphatidylserine antibody reactivity against human first-trimester placental trophoblasts. Am J Obstet Gynecol 1995; 172: 1592–1597.

23.

Franklin

Kutteh

. Antiphospholipid antibodies (APA) and recurrent pregnancy loss: Treating a unique APA positive population. Hum Reprod 2002; 17: 2981–2985.

24.

Sater

Finan

Abu-Hijleh

Almawi

. Anti-phosphatidylserine, anti-cardiolipin, anti-beta2 glycoprotein I and anti-prothrombin antibodies in recurrent miscarriage at 8–12 gestational weeks. Eur J Obstet Gynecol Reprod Biol 2012; 163: 170–174.

25.

Lopez

Dier

Lopez

Merrill

Fink

. Anti-beta 2-glycoprotein I and antiphosphatidylserine antibodies are predictors of arterial thrombosis in patients with antiphospholipid syndrome. Am J Clin Pathol 2004; 121: 142–149.

26.

Velayuthaprabhu

Archunan

. Evaluation of anticardiolipin antibodies and antiphosphatidylserine antibodies in women with recurrent abortion. Indian J Med Sci 2005; 59: 347–352.

27.

Jafarzadeh

Poorgholami

Nemati

Rezayati

. High serum levels of rheumatoid factor and anti-phosphatidylserine antibody in patients with ischemic heart disease. Iran J Immunol 2011; 8: 34–44.

28.

Giannakopoulos

Passam

Ioannou

Krilis

. How we diagnose the antiphospholipid syndrome. Blood 2009; 113: 985–994.

29.

Wong

Favaloro

. Antiphospholipid antibodies and the antiphospholipid syndrome. I: Pathogenesis, clinical features, diagnosis, and management. Preface. Semin Thromb Hemost 2008; 34: 213–218.